Literature DB >> 15661136

Decreased perforin and granzyme B expression in senescent HIV-1-specific cytotoxic T lymphocytes.

Otto O Yang1, Holly Lin, Mirabelle Dagarag, Hwee L Ng, Rita B Effros, Christel H Uittenbogaart.   

Abstract

Cytotoxic T lymphocyte (CTL) senescence may be an important mechanism of immune failure in HIV-1 infection. We find that senescence of HIV-1-specific CTL clones causes loss of killing activity, preventable by transduction with telomerase. Furthermore, senescence is associated with reduced expression of the effector molecules granzyme and perforin, suggesting CTL "exhaustion" can result in hypofunction. These results agree with other studies showing that HIV-1-specific CTL exhibit abnormal phenotypes in vivo, and suggest the possibility that chronic turnover is an important mechanism of antiviral failure in HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661136     DOI: 10.1016/j.virol.2004.11.028

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

1.  Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence.

Authors:  Jeffrey N Dock; Rita B Effros
Journal:  Aging Dis       Date:  2011-10       Impact factor: 6.745

Review 2.  Immunosenescence: a key player in cancer development.

Authors:  Jingyao Lian; Ying Yue; Weina Yu; Yi Zhang
Journal:  J Hematol Oncol       Date:  2020-11-10       Impact factor: 17.388

Review 3.  Telomere/telomerase dynamics within the human immune system: effect of chronic infection and stress.

Authors:  Rita B Effros
Journal:  Exp Gerontol       Date:  2010-09-15       Impact factor: 4.032

Review 4.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  Interleukin-12 is necessary for the priming of CD4+ T cells required during the elicitation of HIV-1 gp120-specific cytotoxic T-lymphocyte function.

Authors:  Shalini Gupta; Ramanamurthy Boppana; Gyan C Mishra; Bhaskar Saha; Debashis Mitra
Journal:  Immunology       Date:  2008-02-20       Impact factor: 7.397

6.  p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes.

Authors:  Abdul M Mondal; Izumi Horikawa; Sharon R Pine; Kaori Fujita; Katherine M Morgan; Elsa Vera; Sharlyn J Mazur; Ettore Appella; Borivoj Vojtesek; Maria A Blasco; David P Lane; Curtis C Harris
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

7.  High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088).

Authors:  Adriana Weinberg; Petronella Muresan; Terence Fenton; Kelly Richardson; Teresa Dominguez; Anthony Bloom; Elizabeth Petzold; Patricia Anthony; Coleen K Cunningham; Stephen A Spector; Sharon Nachman; George K Siberry; Edward Handelsman; Patricia M Flynn
Journal:  Hum Vaccin Immunother       Date:  2013-01-31       Impact factor: 3.452

8.  Age-dependent association between low frequency of CD27/CD28 expression on pp65 CD8+ T cells and cytomegalovirus replication after transplantation.

Authors:  Sara Cantisán; Julián Torre-Cisneros; Rosario Lara; Alberto Rodríguez-Benot; Francisco Santos; Juan Gutiérrez-Aroca; Inmaculada Gayoso; Marcelino González-Padilla; Manuel Casal; Antonio Rivero; Rafael Solana
Journal:  Clin Vaccine Immunol       Date:  2009-08-05

9.  Enhancement of cytotoxic T-lymphocyte response in aged mice by a novel treatment with recombinant AdIL-12 and wild-type adenovirus in rapid succession.

Authors:  Jian Chen; John Wang; Jun Li; Qi Wu; Fei Chu Lim; Pingar Yang; Hui-Chen Hsu; David T Curiel; John D Mountz
Journal:  Mol Ther       Date:  2008-06-10       Impact factor: 11.454

10.  CD57 expression by T cells in the female genital tract of HIV-zx1 infected women.

Authors:  Lenine J Liebenberg; Adebayo Lawrence Adedeji; Darren P Martin; Pam P Gumbi; Lynette Denny; Jo-Ann S Passmore
Journal:  Clin Immunol       Date:  2010-01-25       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.